Osaic Holdings’s GSK GSK Stock Holding History

Osaic Holdings’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13.3M	Buy	253,971 +28,016	+12%	+$1.48M	0.02%	857
2026 Q1	$12.5M	Buy	225,955 +12,822	+6%	+$695K	0.02%	779
2025 Q4	$10.5M	Sell	213,133 -21,008	-9%	-$980K	0.02%	903
2025 Q3	$9.61M	Sell	234,141 -105,973	-31%	-$4.14M	0.01%	1036
2025 Q2	$13.1M	Buy	340,114 +147,263	+76%	+$5.63M	0.02%	684
2025 Q1	$7.48M	Sell	192,851 -34,153	-15%	-$1.25M	0.02%	844
2024 Q4	$7.68M	Sell	227,004 -27,676	-11%	-$996K	0.02%	800
2024 Q3	$10.4M	Sell	254,680 -44,580	-15%	-$1.82M	0.02%	653
2024 Q2	$11.5M	Sell	299,260 -32,137	-10%	-$1.35M	0.03%	581
2024 Q1	$14.2M	Sell	331,397 -163,476	-33%	-$6.74M	0.03%	537
2023 Q4	$18.3M	Sell	494,873 -57,048	-10%	-$2.05M	0.03%	513
2023 Q3	$20M	Buy	551,921 +173,411	+46%	+$6.15M	0.03%	538
2023 Q2	$13.5M	Buy	378,510 +26,027	+7%	+$934K	0.02%	626
2023 Q1	$12.6M	Buy	352,483 +9,035	+3%	+$316K	0.02%	653
2022 Q4	$12.1M	Buy	343,448 +16,436	+5%	+$547K	0.02%	647
2022 Q3	$9.62M	Sell	327,012 -7,007	-2%	-$266K	0.02%	682
2022 Q2	$18.2M	Sell	334,019 -84,219	-20%	-$4.65M	0.04%	413
2022 Q1	$21.9M	Buy	418,238 +22,716	+6%	+$1.23M	0.04%	398
2021 Q4	$21.8M	Buy	395,522 +29,016	+8%	+$1.51M	0.04%	402
2021 Q3	$17.5M	Sell	366,506 -1	-0%	-$50	0.04%	442
2021 Q2	$18.3M	Buy	366,507 +24,045	+7%	+$1.16M	0.04%	417
2021 Q1	$15.3M	Buy	342,462 +69,816	+26%	+$3.17M	0.04%	433
2020 Q4	$12.5M	Buy	272,646 +17,296	+7%	+$794K	0.03%	451
2020 Q3	$12M	Sell	255,350 -27,805	-10%	-$1.39M	0.04%	409
2020 Q2	$14.4M	Sell	283,155 -241,665	-46%	-$12.4M	0.05%	333
2020 Q1	$13.7M	Buy	+524,820	New	+$28M	0.06%	299

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Osaic Holdings's GSK Position: Q2 2026 in Review

Osaic Holdings increased its GSK (GSK) stake by 12% in Q2 2026, buying an estimated $1.48M and bringing the position to 253,971 shares worth $13.3M. The position accounts for 0.02% of the portfolio, ranked #857.

Osaic Holdings first reported a position in GSK in Q1 2020 and has held it in 26 quarters since. The position peaked at $21.9M in Q1 2022. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Osaic Holdings held 253,971 shares of GSK worth $13.3M as of Q2 2026.
Osaic Holdings bought 28,016 GSK shares in Q2 2026, an estimated $1.48M.
GSK made up 0.02% of Osaic Holdings's portfolio in Q2 2026, its #857 holding.
Osaic Holdings first reported a position in GSK in Q1 2020 and has held it in 26 quarters since.
Osaic Holdings's GSK position peaked at $21.9M in Q1 2022.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.